Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor
NCT03667092
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
47
Enrollment
OTHER
Sponsor class
Conditions
Midgut Neuroendocrine Tumors
Interventions
BIOLOGICAL:
non-drug intervention type
Sponsor
University Hospital, Toulouse